Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 0.8660
-0.0170 (-1.93%)
Sep 11, 2026, 5:36 PM CET
Advicenne Revenue
In the year 2025, Advicenne had annual revenue of 7.11M EUR with 24.16% growth. Advicenne had revenue of 3.84M in the half year ending December 31, 2025, with 118.30% growth.
Revenue
7.11M
Revenue Growth
+24.16%
P/S Ratio
1.97
Revenue / Employee
582.18K
Employees
11
Market Cap
12.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.11M | 1.38M | 24.16% |
| Dec 31, 2024 | 5.73M | 2.24M | 64.37% |
| Dec 31, 2023 | 3.48M | 475.00K | 15.79% |
| Dec 31, 2022 | 3.01M | -759.00K | -20.15% |
| Dec 31, 2021 | 3.77M | 202.00K | 5.67% |
| Dec 31, 2020 | 3.57M | 981.00K | 37.96% |
| Dec 31, 2019 | 2.58M | -4.34M | -62.68% |
| Dec 31, 2018 | 6.92M | 4.35M | 169.21% |
| Dec 31, 2017 | 2.57M | 679.00K | 35.87% |
| Dec 31, 2016 | 1.89M | 1.08M | 132.27% |
| Dec 31, 2015 | 815.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 28.60M |
| Nicox | 16.77M |
| Poxel | 7.66M |
| Aelis Farma | 2.08M |
| Plant Advanced Technologies | 1.65M |
| Aton | 661.00K |
| GenSight Biologics | 652.00K |
| TME Pharma | 27.00K |